Showing 1 - 19 results of 19 for search 'Mark S Stein', query time: 0.07s
Refine Results
-
1
-
2
Precision Medicine Care in ADHD: The Case for Neural Excitation and Inhibition by Ping C. Mamiya, Anne B. Arnett, Mark A. Stein
Published 2021-01-01
Article -
3
-
4
-
5
-
6
The GLP-1 receptor is expressed in vivo by human metastatic prostate cancer by Mark S Stein, Victor Kalff, Scott G Williams, Declan G Murphy, Peter G Colman, Michael S Hofman
Published 2024-01-01
Article -
7
-
8
-
9
Reduced Glx and GABA Inductions in the Anterior Cingulate Cortex and Caudate Nucleus Are Related to Impaired Control of Attention in Attention-Deficit/Hyperactivity Disorder by Ping C. Mamiya, Todd L. Richards, Richard A. E. Edden, Adrian K. C. Lee, Mark A. Stein, Patricia K. Kuhl
Published 2022-04-01
Article -
10
Screening for parent and child ADHD in urban pediatric primary care: pilot implementation and stakeholder perspectives by Joyce H. L. Lui, Christina M. Danko, Tricia Triece, Ian M. Bennett, Donna Marschall, Nicole E. Lorenzo, Mark A. Stein, Andrea Chronis-Tuscano
Published 2023-07-01
Article -
11
Ropivacaine 0.025% mixed with fentanyl 3.0 μg/ml and epinephrine 0.5 μg/ml is effective for epidural patient-controlled analgesia after cesarean section by Shaul Cohen, Renu Chhokra, Mark H Stein, John T Denny, Shruti Shah, Adil Mohiuddin, Rotem Naftalovich, Rong Zhao, Anna Pashkova, Noah Rolleri, Arpan G Patel, Christine W Hunter-Fratzola
Published 2015-01-01
Article -
12
764 A phase 1, first-in-human (FIH), open-label, dose-finding and expansion study of XmAb808, a B7H3 x CD28 bispecific antibody, in combination with pembrolizumab in patients with... by Benjamin Thompson, Li Yao, Yana G Najjar, Siwen Hu-Lieskovan, Raphael Clynes, Bartosz Chmielowski, Mark N Stein, Sarina A Piha-Paul, Patricia McGovern, Judy S Wang, Benjamin Garmezy, Manojkumar Bupathi, Jitendra Kanodia
Published 2023-11-01Article -
13
Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy by Julie N. Graff, Julie N. Graff, Mark N. Stein, Rishi Surana, Luai Al Rabadi, Luai Al Rabadi, Eric Liu, Lawrence Fong, Shawna Bailey, Emile Latour, Timothy A. Newby, Amy E. Moran, Tomasz M. Beer
Published 2020-08-01
Article -
14
665 Immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer: A clinical trial in progress by Neal Shore, Robert Dreicer, Matthew Zibelman, Mark N Stein, Ralph J Hauke, Russell Pachynski, Bethan Jones, Jessica Hawley, Charlotte Davis, Katie Anderson, Antonella Vardeu, Margaret A Marshall, Vicky Wheeler, Sarah Sebastian, Kevin Kayvan Zarrabi, Brian Miles, Jennifer Bendall
Published 2023-11-01Article -
15
Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer by Xiang‐Lin Tan, Jian‐Yu E, Yong Lin, Timothy R. Rebbeck, Shou‐En Lu, Mingyi Shang, William K. Kelly, Anthony D'Amico, Mark N. Stein, Lanjing Zhang, Thomas L. Jang, Isaac Yi Kim, Kitaw Demissie, Anna Ferrari, Grace Lu‐Yao
Published 2020-04-01
Article -
16
Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer by Bertram E. Yuh, Young Suk Kwon, Brian M. Shinder, Eric A. Singer, Thomas L. Jang, Sinae Kim, Mark N. Stein, Tina Mayer, Anna Ferrari, Nara Lee, Rahul R. Parikh, Nora Ruel, Wun-Jae Kim, Shigeo Horie, Seok-Soo Byun, Thomas E. Ahlering, Isaac Yi Kim
Published 2019-09-01
Article -
17
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma. by Bert H O'Neil, John M Wallmark, David Lorente, Elena Elez, Judith Raimbourg, Carlos Gomez-Roca, Samuel Ejadi, Sarina A Piha-Paul, Mark N Stein, Albiruni R Abdul Razak, Katia Dotti, Armando Santoro, Roger B Cohen, Marlena Gould, Sanatan Saraf, Karen Stein, Sae-Won Han
Published 2017-01-01
Article -
18
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy by Karen A. Autio, Emmanuel S. Antonarakis, Tina M. Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan, Michael J. Morris, Susan F. Slovin, Elisabeth I. Heath, Scott T. Tagawa, Dana E. Rathkopf, Matthew I. Milowsky, Michael R. Harrison, Tomasz M. Beer, Arjun V. Balar, Andrew J. Armstrong, Daniel J. George, Channing J. Paller, Arlyn Apollo, Daniel C. Danila, Julie N. Graff, Luke Nordquist, Erica S. Dayan Cohn, Kin Tse, Nicole A. Schreiber, Glenn Heller, Howard I. Scher
Published 2021-12-01
Article -
19
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration by Mark N. Stein, Jyoti Malhotra, Rohinton S. Tarapore, Usha Malhotra, Ann W. Silk, Nancy Chan, Lorna Rodriguez, Joseph Aisner, Robert D. Aiken, Tina Mayer, Bruce G. Haffty, Jenna H. Newman, Salvatore M. Aspromonte, Praveen K. Bommareddy, Ricardo Estupinian, Charles B. Chesson, Evita T. Sadimin, Shengguo Li, Daniel J. Medina, Tracie Saunders, Melissa Frankel, Aparna Kareddula, Sherrie Damare, Elayne Wesolowsky, Christian Gabel, Wafik S. El-Deiry, Varun V. Prabhu, Joshua E. Allen, Martin Stogniew, Wolfgang Oster, Joseph R. Bertino, Steven K. Libutti, Janice M. Mehnert, Andrew Zloza
Published 2019-05-01
Article